# TAR-0520 Gel in Hand and Foot Syndrome

> **NCT07457671** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Tarian Pharma** · enrollment: 25 (estimated)

## Conditions studied

- Hand and Foot Syndrome

## Interventions

- **DRUG:** TAR-0520 gel

## Key facts

- **NCT ID:** NCT07457671
- **Lead sponsor:** Tarian Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2027-03
- **Final completion:** 2027-06
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07457671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07457671, "TAR-0520 Gel in Hand and Foot Syndrome". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT07457671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*